These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809 [TBL] [Abstract][Full Text] [Related]
11. Sex differences in dopamine- and vesicular monoamine-transporter functions. Dluzen DE; McDermott JL Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858 [TBL] [Abstract][Full Text] [Related]
12. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters. Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. Brown JM; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904 [TBL] [Abstract][Full Text] [Related]